You are here

  • Home
  • Archive
  • Volume 7, Issue 2
  • Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial

Article info

Article menu

Download PDFPDF

XML
Rheumatoid arthritis
Original research
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial

Authors

  • Sofia Pazmino Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Annelies Boonen Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+, Maastricht, Limburg, The NetherlandsCare and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Limburg, The Netherlands PubMed articlesGoogle scholar articles
  • Diederik De Cock Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Veerle Stouten Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Johan Joly Department of Rheumatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Delphine Bertrand Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • René Westhovens Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, BelgiumDepartment of Rheumatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Patrick Verschueren Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, BelgiumDepartment of Rheumatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sofia Pazmino; sofia.pazmino{at}kuleuven.be
View Full Text

Citation

Pazmino S, Boonen A, De Cock D, et al
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial
RMD Open 2021;7:e001615. doi: 10.1136/rmdopen-2021-001615

Publication history

  • Received February 3, 2021
  • Accepted May 12, 2021
  • First published May 24, 2021.
Online issue publication 
January 11, 2024

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.